These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Persistent Empiric COPD Diagnosis and Treatment After Pulmonary Function Test Showed No Obstruction. Fortis S; Corazalla EO; Jacobs DR; Kim HJ Respir Care; 2016 Sep; 61(9):1192-200. PubMed ID: 27165420 [TBL] [Abstract][Full Text] [Related]
25. Understanding the GOLD 2011 Strategy as applied to a real-world COPD population. Vestbo J; Vogelmeier C; Small M; Higgins V Respir Med; 2014 May; 108(5):729-36. PubMed ID: 24675239 [TBL] [Abstract][Full Text] [Related]
26. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Qaseem A; Wilt TJ; Weinberger SE; Hanania NA; Criner G; van der Molen T; Marciniuk DD; Denberg T; Schünemann H; Wedzicha W; MacDonald R; Shekelle P; ; ; ; Ann Intern Med; 2011 Aug; 155(3):179-91. PubMed ID: 21810710 [TBL] [Abstract][Full Text] [Related]
27. Treatment patterns for patients hospitalized with chronic obstructive pulmonary disease. Amin AN; Bollu V; Stensland MD; Netzer L; Ganapathy V Am J Health Syst Pharm; 2018 Mar; 75(6):359-366. PubMed ID: 29523532 [TBL] [Abstract][Full Text] [Related]
28. An integrated approach to the medical treatment of chronic obstructive pulmonary disease. Rosenberg SR; Kalhan R Med Clin North Am; 2012 Jul; 96(4):811-26. PubMed ID: 22793946 [TBL] [Abstract][Full Text] [Related]
29. Reliability and usefulness of spirometry performed during admission for COPD exacerbation. Fernández-Villar A; Represas-Represas C; Mouronte-Roibás C; Ramos-Hernández C; Priegue-Carrera A; Fernández-García S; López-Campos JL PLoS One; 2018; 13(3):e0194983. PubMed ID: 29579084 [TBL] [Abstract][Full Text] [Related]
30. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing? Kjeldgaard P; Dahl R; Løkke A; Ulrik CS Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573 [TBL] [Abstract][Full Text] [Related]
31. Expiratory flow limitation relates to symptoms during COPD exacerbations requiring hospital admission. Jetmalani K; Timmins S; Brown NJ; Diba C; Berend N; Salome CM; Wen FQ; Chen P; King GG; Farah CS Int J Chron Obstruct Pulmon Dis; 2015; 10():939-45. PubMed ID: 25999709 [TBL] [Abstract][Full Text] [Related]
32. The objective evaluation of obstructive pulmonary diseases with spirometry. Ozkaya S; Dirican A; Tuna T Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884 [TBL] [Abstract][Full Text] [Related]
33. Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol. Singh D; Maleki-Yazdi MR; Tombs L; Iqbal A; Fahy WA; Naya I Int J Chron Obstruct Pulmon Dis; 2016; 11():1413-24. PubMed ID: 27445468 [TBL] [Abstract][Full Text] [Related]
34. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD. Ben Saad H; Préfaut C; Tabka Z; Zbidi A; Hayot M Pulm Pharmacol Ther; 2008 Oct; 21(5):767-73. PubMed ID: 18555715 [TBL] [Abstract][Full Text] [Related]
35. The effects of extrafine beclometasone/formoterol (BDP/F) on lung function, dyspnea, hyperinflation, and airway geometry in COPD patients: novel insight using functional respiratory imaging. De Backer J; Vos W; Vinchurkar S; Van Holsbeke C; Poli G; Claes R; Salgado R; De Backer W J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):88-99. PubMed ID: 25004168 [TBL] [Abstract][Full Text] [Related]
36. Don't diagnose mild COPD without confirming airway obstruction after an inhaled bronchodilator. Enright P; Quanjer P COPD; 2007 Jun; 4(2):89-90. PubMed ID: 17530501 [No Abstract] [Full Text] [Related]
37. Physical activity in COPD patients decreases short-acting bronchodilator use and the number of exacerbations. Katajisto M; Koskela J; Lindqvist A; Kilpeläinen M; Laitinen T Respir Med; 2015 Oct; 109(10):1320-5. PubMed ID: 26298024 [TBL] [Abstract][Full Text] [Related]
38. A score to predict short-term risk of COPD exacerbations (SCOPEX). Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896 [TBL] [Abstract][Full Text] [Related]
39. Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies. Martinez FJ; Rabe KF; Lipworth BJ; Arora S; Jenkins M; Martin UJ; Reisner C Int J Chron Obstruct Pulmon Dis; 2020; 15():99-106. PubMed ID: 32021148 [TBL] [Abstract][Full Text] [Related]
40. Sex Differences in Veterans Admitted to the Hospital for Chronic Obstructive Pulmonary Disease Exacerbation. Bade BC; DeRycke EC; Ramsey C; Skanderson M; Crothers K; Haskell S; Bean-Mayberry B; Brandt C; Bastian LA; Akgün KM Ann Am Thorac Soc; 2019 Jun; 16(6):707-714. PubMed ID: 30822098 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]